Patent ID: 8999659
Filing Date: 2015-04-07
Classification: G01N

Abstract:
1. A method for assessing for presence of non-acute heart failure in a human subject at risk for heart failure, the method comprising: measuring a cardiac BIN1 protein level in a blood, serum or plasma sample obtained from the subject, wherein the measuring is performed by contacting the blood, serum or plasma sample with an anti-cardiac BIN1 antibody; comparing the cardiac BIN1 protein level to a normal cardiac BIN1 protein level; and assessing the presence of non-acute heart failure in the subject when the cardiac BIN1 protein level is significantly decreased compared to the normal BIN1 protein level, wherein the normal cardiac BIN1 level is obtained from assaying cardiac BIN1 protein in a blood, serum or plasma sample obtained from a healthy human.